What question did this study set out to answer?

Summarize the molecular pathology, differential diagnostic assays, prognostic gene expression platforms, and therapeutic prediction markers in cutaneous melanoma.

May 11, 2022International Journal of Molecular SciencesOpen Access

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction

View Full Paper

Ask AI

Bookmark

Authors

JTJózsef Tı́márSemmelweis University ALAndrea LadányiNational Institute of Oncology

Discussion

Member takes

Implication

Review synthesizes genomic landscapes, diagnostic signatures, and therapeutic resistance in cutaneous melanoma, highlighting the need for validated predictive biomarkers to guide immunotherapy.

Key Points

Summarize the molecular pathology, differential diagnostic assays, prognostic gene expression platforms, and therapeutic prediction markers in cutaneous melanoma.
Synthesized findings from large-scale cancer genomics initiatives (including TCGA) and genome-wide association studies across hereditary and sporadic melanoma.
Evaluated molecular diagnostic tools (FISH and gene expression profiling) alongside clinical data on targeted therapies and immune checkpoint inhibitors.
Gene expression assays and molecular profiling improve differential diagnosis and staging-based prognostication in malignant melanocytic lesions.
Clinically validated predictive biomarkers remain largely restricted to BRAF mutations, KIT mutations, and tumor mutation burden despite extensive genomic characterization.
Immune checkpoint inhibitors demonstrate robust clinical efficacy, yet secondary acquired mutations frequently cause therapeutic resistance and disease relapse.

Cite This Study

Tı́már et al. (2022) studied this question.

synapsesocial.com/papers/6a09626f16dfdfe7ed340b8c https://doi.org/10.3390/ijms23105384

View Full Paper

Ask AI

Bookmark

Implication

Review synthesizes genomic landscapes, diagnostic signatures, and therapeutic resistance in cutaneous melanoma, highlighting the need for validated predictive biomarkers to guide immunotherapy.

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction

Discussion

Member takes

Implication

Key Points

Cite This Study

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider